Clinical Trials in Denver

Showing 8521-8540 of 18,161 trials

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

NCT02236312

The primary objective of the study is to evaluate the efficacy in wrinkle reduction of a single treatment of three different doses of botulinum toxin compared to placebo, in the treatment of moderate to very severe glabellar frown lines.

Glabellar Frown Lines

Galderma R&D359 participantsStarted Sep 2014

Birmingham, Alabama, United States • Mobile, Alabama, United States • San Diego, California, United States +5 more locations

UNKNOWNPhase 18.4 miles

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

NCT03634982

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) profiles of escalating doses of RMC-4630 monotherapy in adult participants with relapsed/refractory solid tumors and to identify the recommended Phase 2 dose (RP2D).

Solid Tumors

Revolution Medicines, Inc.133 participantsStarted Sep 2018

Scottsdale, Arizona, United States • Duarte, California, United States • Orange, California, United States +9 more locations

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

Find Trials by Condition in Denver

Pilot Evaluation of Hospice Decision Support Tools

Subject Satisfaction With AbobutulinumtoxinA Treatment

A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Evaluation of the Use of Medical Scribes in VAMC Emergency Departments and Specialty Care Clinics

Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH)

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

A Prospective Study of Early Mechanical Stabilization and Bleeding in Disruption of the Pelvic Ring

Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years

Post Market Clinical Protocol - Xtremity Polymer Prosthetic Socket System

Long-term Neurocognitive Sequelae of Subclinical Microembolization During Carotid Interventions

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Open-Label Extension and Safety Study of Talazoparib

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis

Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca